Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-16-027919
Filing Date
2016-07-26
Accepted
2016-07-26 17:55:48
Documents
1
Period of Report
2016-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 7642
  Complete submission text file 0001179110-16-027919.txt   8970
Mailing Address 750 BATTERY ST STE 600 SAN FRANCISCO CA 94111
Business Address
CRAVES FRED B (Reporting) CIK: 0001014095 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 161785248

Mailing Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034
Business Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034 610-527-6790
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations